{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:09:32Z","timestamp":1778875772484,"version":"3.51.4"},"reference-count":115,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,2]],"date-time":"2020-02-02T00:00:00Z","timestamp":1580601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R15 EY029504"],"award-info":[{"award-number":["R15 EY029504"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.bioactmat.2020.01.011","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T23:40:51Z","timestamp":1582328451000},"page":"233-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Evolving role of biomaterials in diagnostic and therapeutic radiation oncology"],"prefix":"10.1016","volume":"5","author":[{"given":"Siyu","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5372-7674","authenticated-orcid":false,"given":"Ravi","family":"Vissapragada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2283-4765","authenticated-orcid":false,"given":"Joseph","family":"Abi Jaoude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5620-303X","authenticated-orcid":false,"given":"Caroline","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0689-387X","authenticated-orcid":false,"given":"Anmol","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-8832","authenticated-orcid":false,"given":"Elisa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2020.01.011_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrc1451","article-title":"Radiation oncology: a century of achievements","volume":"4","author":"Bernier","year":"2004","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib2","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1088\/0031-9155\/59\/6\/R183","article-title":"Advances in kilovoltage x-ray beam dosimetry","volume":"59","author":"Hill","year":"2014","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2190\/PM.40.2.c","article-title":"It's not over when it's over: long-term symptoms in cancer survivors\u2014a systematic review","volume":"40","author":"Harrington","year":"2010","journal-title":"Int. J. Psychiatr. Med."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/stem.318","article-title":"Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited","volume":"28","author":"Pajonk","year":"2010","journal-title":"Stem Cell."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib5","article-title":"Science education - biomaterials","year":"2017","journal-title":"Natl. Inst. Biomed. Imag. Bioeng."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrc.2015.3","article-title":"Biomaterials and emerging anticancer therapeutics: engineering the microenvironment","volume":"16","author":"Gu","year":"2016","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib7","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/aic.690491202","article-title":"Advances in biomaterials, drug delivery, and bionanotechnology","volume":"49","author":"Langer","year":"2003","journal-title":"AIChE J."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib8","article-title":"Challenges in translating from bench to bed-side: pro-angiogenic peptides for ischemia treatment","volume":"24","author":"Petrak","year":"2019","journal-title":"Mol. Basel Switz."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1021\/nn506544b","article-title":"Highly angiogenic peptide nanofibers","volume":"9","author":"Kumar","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bioactmat.2016.09.004","article-title":"Development of peptide inhibitors of HIV transmission","volume":"1","author":"Shi","year":"2016","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib11","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1021\/jacs.5b01549","article-title":"Drug-triggered and cross-linked self-assembling nanofibrous hydrogels","volume":"137","author":"Kumar","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib12","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1016\/j.biomaterials.2011.06.024","article-title":"A review of NIR dyes in cancer targeting and imaging","volume":"32","author":"Luo","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib13","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nmat3877","article-title":"A targeted approach to cancer imaging and therapy","volume":"13","author":"Li","year":"2014","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib15","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.2174\/138161281941131219124142","article-title":"Smart stimuli sensitive nanogels in cancer drug delivery and imaging: a review","volume":"19","author":"Maya","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ultrasmedbio.2016.09.009","article-title":"Polymer-based materials in cancer treatment: from therapeutic carrier and ultrasound contrast agent to theranostic applications","volume":"43","author":"Methachan","year":"2017","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib17","author":"Sartor"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2307\/3578966","article-title":"The biological effectiveness of radon-progeny alpha particles. II. Oncogenic transformation as a function of linear energy transfer","volume":"142","author":"Miller","year":"1995","journal-title":"Radiat. Res."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00324","article-title":"The potential and hurdles of targeted alpha therapy \u2013 clinical trials and beyond","volume":"3","author":"Elgqvist","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib21","series-title":"The 2007 Recommendations of the International Commission on Radiological Protection","author":"Valentin","year":"2008"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/imt.10.114","article-title":"Cancer radioimmunotherapy","volume":"3","author":"Sharkey","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM198203043060906","article-title":"Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody","volume":"306","author":"Miller","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib24","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1200\/JCO.1999.17.6.1851","article-title":"Single-agent monoclonal antibody efficacy in bulky non-Hodgkin\u2019s lymphoma: results of a phase II trial of rituximab","volume":"17","author":"Davis","year":"1999","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib25","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1200\/JCO.1998.16.10.3246","article-title":"Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin\u2019s lymphoma","volume":"16","author":"DeNardo","year":"1998","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib26","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1200\/JCO.2002.11.076","article-title":"Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin\u2019s lymphoma","volume":"20","author":"Witzig","year":"2002","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1200\/JCO.2005.07.040","article-title":"Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-cell lymphoma, progressive after rituximab","volume":"23","author":"Horning","year":"2005","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib28","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1182\/blood-2007-10-117671","article-title":"First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1\/2 trial","volume":"111","author":"Hagenbeek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/cbr.2014.1741","article-title":"Peptide receptor radionuclide therapy: an overview","volume":"30","author":"Dash","year":"2015","journal-title":"Canc. Biother. Radiopharm."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF03345728","article-title":"Peptide receptor therapies in neuroendocrine tumors","volume":"32","author":"Bodei","year":"2009","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib31","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1182\/blood-2003-11-3883","article-title":"Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1\/2 study","volume":"103","author":"Gordon","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib32","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/cncr.22617","article-title":"Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan","volume":"109","author":"Witzig","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib33","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1200\/JCO.2012.45.6400","article-title":"90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial","volume":"31","author":"Morschhauser","year":"2013","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/hon.2513","article-title":"Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with 90 Y ibritumomab tiuxetan in a phase II study","author":"Berinstein","year":"2018","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/10428194.2018.1509322","article-title":"Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years","volume":"60","author":"Provencio","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib36","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s002590000276","article-title":"Phase I\/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin\u2019s lymphoma","volume":"27","author":"Wiseman","year":"2000","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib38","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.7150\/thno.26706","article-title":"Remote loading of liposomes with a 124I-radioiodinated compound and their in vivo evaluation by PET\/CT in a murine tumor model","volume":"8","author":"Engudar","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib39","doi-asserted-by":"crossref","first-page":"13947","DOI":"10.1039\/C9NR04320A","article-title":"Enhancing chemoradiation of colorectal cancer through targeted delivery of raltitrexed by hyaluronic acid coated nanoparticles","volume":"11","author":"Rosch","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib40","article-title":"Multitargeted nanoparticles deliver synergistic drugs across the blood-brain barrier to brain metastases of triple negative breast cancer cells and tumor-associated macrophages","author":"Zhang","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib41","doi-asserted-by":"crossref","first-page":"29592","DOI":"10.3390\/ijms161226183","article-title":"Heavy metals and human health: mechanistic insight into toxicity and counter defense system of antioxidants","volume":"16","author":"Jan","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2478\/intox-2014-0009","article-title":"Toxicity, mechanism and health effects of some heavy metals","volume":"7","author":"Jaishankar","year":"2014","journal-title":"Interdiscipl. Toxicol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib43","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1021\/nn405773r","article-title":"Multifunctional albumin-MnO\u2082 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response","volume":"8","author":"Prasad","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5946\/ce.2013.46.1.30","article-title":"Photodynamic therapy for Barrett's esophagus and esophageal carcinoma","volume":"46","author":"Qumseya","year":"2013","journal-title":"Clin. Endosc."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib45","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jdv.16017","article-title":"European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications\u2013actinic keratoses, Bowen's disease and basal cell carcinomas","volume":"33","author":"Morton","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib46","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrc1071","article-title":"Photodynamic therapy for cancer","volume":"3","author":"Dolmans","year":"2003","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib47","first-page":"393","article-title":"Photodynamic therapy for cancer: principles","volume":"16","author":"Wilson","year":"2002","journal-title":"Chin. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib48","first-page":"505","article-title":"Basic principles, applications in oncology and improved selectivity of photodynamic therapy","volume":"23","author":"Vrouenraets","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib49","first-page":"939","article-title":"New directions in photodynamic therapy","volume":"48","author":"Gudgin","year":"2002","journal-title":"Cell. Mol. Biol. Noisy--Gd. Fr."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02256427","article-title":"A light in multidrug resistance: photodynamic treatment of multidrug-resistant tumors","volume":"10","author":"Capella","year":"2003","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib51","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib52","first-page":"27","article-title":"Photosensitizers in clinical PDT, photodiagnosis photodyn","volume":"1","author":"Allison","year":"2004","journal-title":"Ther"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib53","doi-asserted-by":"crossref","first-page":"1704303","DOI":"10.1002\/adma.201704303","article-title":"Stable metal\u2013organic frameworks: design, synthesis, and applications","volume":"30","author":"Yuan","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib54","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1038\/s41467-018-06655-7","article-title":"Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy","volume":"9","author":"Ni","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib55","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.7150\/thno.31918","article-title":"Bioengineering of metal-organic frameworks for nanomedicine","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib56","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8507924","article-title":"Combination of photodynamic therapy with radiotherapy for cancer treatment","author":"Xu","year":"2016","journal-title":"J. Nanomater."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib57","first-page":"1","article-title":"Investigation of combined photodynamic and radiotherapy effects of gallium phthalocyanine chloride on MCF-7 breast cancer cells","author":"Mayahi","year":"2019","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib58","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1021\/acsnano.8b09221","article-title":"Quercetin-modified metal\u2013organic frameworks for dual sensitization of radiotherapy in tumor tissues by inhibiting the carbonic anhydrase IX","volume":"13","author":"Ma","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib59","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/molecules23040907","article-title":"Liposomal drug delivery systems and anticancer drugs","volume":"23","author":"Olusanya","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib60","first-page":"330","article-title":"Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer","volume":"2","author":"Kwatra","year":"2013","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib61","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204063","article-title":"Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: an in vitro proof of concept study","volume":"13","author":"Besse","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2017.01.025","article-title":"To heat or not to heat: challenges with clinical translation of thermosensitive liposomes","volume":"249","author":"Dou","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib64","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1102\/1470-7330.2004.0053","article-title":"Improvements in radiotherapy practice: the impact of new imaging technologies","volume":"4","author":"Driver","year":"2004","journal-title":"Canc. Imag."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib65","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/molecules23020288","article-title":"Liposomes: clinical applications and potential for image-guided drug delivery","volume":"23","author":"Lamichhane","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib66","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib67","first-page":"927","article-title":"Metallic nanoparticles: technology overview & drug delivery applications in oncology, Expert Opin","volume":"7","author":"Ahmad","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib68","doi-asserted-by":"crossref","first-page":"S505","DOI":"10.1016\/j.ijrobp.2014.05.1552","article-title":"Radiopaque polymer hydrogel used as a fiducial marker in gynecologic brachytherapy","volume":"90","author":"Bair","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib69","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1378\/chest.12-1691","article-title":"Novel applications of an injectable radiopaque hydrogel tissue marker for management of thoracic malignancies","volume":"143","author":"de Souza Lawrence","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib71","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.1997.15.3.987","article-title":"Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation","volume":"15","author":"Muggia","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib72","first-page":"463","article-title":"Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi-sarcoma","author":"Bogner","year":"1994","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib73","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1200\/JCO.2006.10.5460","article-title":"Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression","volume":"25","author":"Orlowski","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib74","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1166\/jbn.2009.1016","article-title":"Liposomal nanocarriers for tumor imaging","volume":"5","author":"Erdogan","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib75","series-title":"Composite Nanoparticles for Gene Delivery","first-page":"111","author":"Wang","year":"2014"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00216-011-5482-5","article-title":"Composite nanoparticles: the best of two worlds","volume":"402","author":"Janczak","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib77","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1359-0294(03)00008-6","article-title":"Properties of polymer\u2013nanoparticle composites","volume":"8","author":"Schmidt","year":"2003","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib78","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2013\/148578","article-title":"Applications of nanoparticles for MRI cancer diagnosis and therapy","volume":"2013","author":"Blasiak","year":"2013","journal-title":"J. Nanomater."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib79","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2019.03.043","article-title":"Copper sulfide: an emerging adaptable nanoplatform in cancer theranostics","volume":"562","author":"Poudel","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib80","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/adhm.201400651","article-title":"Injectable colloidal gold for use in intrafractional 2D image\u2010guided radiation therapy","volume":"4","author":"J\u00f8lck","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib81","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2217\/nnm.12.165","article-title":"Gold nanoparticle imaging and radiotherapy of brain tumors in mice","volume":"8","author":"Hainfeld","year":"2013","journal-title":"Nanomed."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib82","first-page":"373","article-title":"Toxic effects of the Fe2O3 nanoparticles on the liver and lung tissue","volume":"116","author":"Sadeghi","year":"2015","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib83","doi-asserted-by":"crossref","first-page":"418","DOI":"10.7150\/thno.14018","article-title":"Gadolinium-based nanoparticles and radiation therapy for multiple brain melanoma metastases: proof of concept before phase I trial","volume":"6","author":"Kotb","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib84","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12645-014-0004-8","article-title":"Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment","volume":"5","author":"Le Duc","year":"2014","journal-title":"Canc. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib85","doi-asserted-by":"crossref","DOI":"10.1098\/rsta.2017.0180","article-title":"Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus","volume":"375","author":"Garcia","year":"2017","journal-title":"Philos. Transact. A Math. Phys. Eng. Sci."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib86","doi-asserted-by":"crossref","first-page":"e1449","DOI":"10.1002\/wnan.1449","article-title":"Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment","volume":"9","author":"Riley","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib87","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11307-013-0676-1","article-title":"Comparison of PET imaging with 64 Cu-liposomes and 18 F-FDG in the 7, 12-dimethylbenz [a] anthracene (DMBA)-Induced hamster buccal pouch model of oral dysplasia and squamous cell carcinoma","volume":"16","author":"Mahakian","year":"2014","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib88","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/bmj.322.7291.876","article-title":"Synchronous chemoradiation for squamous carcinomas","volume":"322","author":"Tobias","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib89","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0959-8049(11)70097-1","article-title":"Synchronous chemo-radiation can reduce local recurrence in early stage breast cancer: results of the SECRAB Trial (ISRCTN: 84214355) presented on behalf of the SECRAB Steering Committee","volume":"47","author":"Fernando","year":"2011","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib90","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/ijms17010102","article-title":"Cellular pathways in response to ionizing radiation and their targetability for tumor radiosensitization","volume":"17","author":"Maier","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib91","article-title":"Randomized controlled trial of late-course concurrent versus sequential chemoradiotherapy after mastectomy and axillary surgery in locally advanced breast cancer","volume":"96","author":"Lu","year":"2017","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib92","first-page":"44","article-title":"Liposomal-encapsulated chemotherapy: preliminary results of a phase I study of a novel liposomal paclitaxel","volume":"15","author":"Treat","year":"2001","journal-title":"Oncol. Williston Park NY"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib93","first-page":"320","article-title":"Improving chemoradiotherapy with nanoparticle therapeutics","volume":"2","author":"Eblan","year":"2013","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib94","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1748-717X-6-135","article-title":"Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts","volume":"6","author":"Hagtvet","year":"2011","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib95","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/ijms19061717","article-title":"Protein polymer-based nanoparticles: fabrication and medical applications","volume":"19","author":"DeFrates","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib96","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/IJN.S198353","article-title":"Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives","volume":"14","author":"Mukherjee","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib97","series-title":"Chemotherapy or Not? Clinical Studies of Poly(L-Glutamic Acid)-Paclitaxel","year":"2017"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib98","series-title":"Phase Ib\/II Study of Neoadjuvant Chemoradiotherapy with CRLX101 and Capecitabine for Locally Advanced Rectal Cancer","author":"Wang","year":"2017"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib99","article-title":"Iron oxide nanoparticles in photothermal therapy","volume":"23","author":"Estelrich","year":"2018","journal-title":"Mol. J. Synth. Chem. Nat. Prod. Chem."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib100","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.2174\/1381612825666181120160959","article-title":"Advanced carbon-based nanoplatforms combining drug delivery and thermal therapy for cancer treatment","volume":"24","author":"Xu","year":"2018","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib101","first-page":"1","article-title":"Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses","author":"Chao","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib102","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/marc.201600189","article-title":"Polymeric thioxanthones as potential anticancer and radiotherapy agents","volume":"37","author":"Yilmaz","year":"2016","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib103","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.molonc.2015.01.006","article-title":"Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to \u03b3\u2010irradiation","volume":"9","author":"Kievit","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib104","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2016.09.026","article-title":"Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: from theoretical considerations to practical applications","volume":"241","author":"Boissenot","year":"2016","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179131","article-title":"Temperature sensitive liposomes combined with thermal ablation: effects of duration and timing of heating in mathematical models and in vivo","volume":"12","author":"Rossmann","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib106","doi-asserted-by":"crossref","first-page":"19604","DOI":"10.1039\/C7RA01009E","article-title":"Near infrared laser-controlled drug release of thermoresponsive microgel encapsulated with Fe3O4 nanoparticles","volume":"7","author":"Qi","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib107","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1586\/14737140.4.2.283","article-title":"Radiation-guided drug delivery systems","volume":"4","author":"Stacy","year":"2004","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib108","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1200\/JCO.2014.55.0699","article-title":"Nanotechnology in radiation oncology","volume":"32","author":"Wang","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib109","doi-asserted-by":"crossref","first-page":"S705","DOI":"10.1016\/j.ijrobp.2008.06.531","article-title":"Radiation-guided drug delivery of nanoparticle albumin-bound paclitaxel to lung cancer","volume":"72","author":"Hariri","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2354.1999.00153.x","article-title":"Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings","volume":"8","author":"Porock","year":"1999","journal-title":"Eur. J. Canc. Care"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib111","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0360-3016(02)02756-6","article-title":"Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma","volume":"53","author":"Lee","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib112","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/ten.tea.2008.0018","article-title":"Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect","volume":"15","author":"Leu","year":"2008","journal-title":"Tissue Eng."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib113","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1021\/am300783d","article-title":"Polymer-composite materials for radiation protection","volume":"4","author":"Nambiar","year":"2012","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib114","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/wnan.100","article-title":"Tissue scaffolds for skin wound healing and dermal reconstruction","volume":"2","author":"Zhong","year":"2010","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.bioactmat.2020.01.011_bib115","first-page":"133","article-title":"Stability of polaprezinc-containing oral rinse and its clinical effectiveness against radiotherapy-induced oral mucositis","volume":"15","author":"Nakayama","year":"2013","journal-title":"Iyakuhin Johogaku"},{"key":"10.1016\/j.bioactmat.2020.01.011_bib116","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.prro.2016.10.004","article-title":"Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall","volume":"7","author":"Fischer-Valuck","year":"2017","journal-title":"Pract. Radiat. Oncol."}],"updated-by":[{"DOI":"10.1016\/j.bioactmat.2020.11.010","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000}}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X20300116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X20300116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T07:37:29Z","timestamp":1589355449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X20300116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2452199X20300116"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2020.01.011","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bioactmat.2020.11.010","asserted-by":"object"}]},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving role of biomaterials in diagnostic and therapeutic radiation oncology","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2020.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}